Characterization of cerebrospinal fluid (CSF) and plasma NPY levels in normal volunteers over a 24-h timeframe

Psychoneuroendocrinology

Volumn 38, Issue 10, 2013, Pages 2378-2382

  Baker, Dewleen G ^a,b,c   Bertram, Tobias Moeller ^a,b,c   Patel, Piyush M ^b,c   Barkauskas, Donald A ^d   Clopton, Paul ^c   Patel, Sejal ^c   Geracioti, Thomas D ^e   Haji, Uzair ^c   O'Connor, Daniel T ^b   Nievergelt, Caroline M ^a,b,c   Hauger, Richard L ^a,b,c  

^a VA CENTER OF EXCELLENCE FOR STRESS AND MENTAL HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Blood brain barrier; Cerebrospinal fluid, CSF; Depression; Genetics; Neuropeptide Y, NPY; Plasma; Posttraumatic stress disorder

Indexed keywords

NEUROPEPTIDE Y;

ADULT; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; CORRELATIONAL STUDY; HUMAN; HUMAN EXPERIMENT; MALE; MENTAL HEALTH; MENTAL STRESS; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN SECRETION;

BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID, CSF; DEPRESSION; GENETICS; NEUROPEPTIDE Y, NPY; PLASMA; POSTTRAUMATIC STRESS DISORDER;

ADULT; CIRCADIAN RHYTHM; HEALTHY VOLUNTEERS; HUMANS; MALE; NEUROPEPTIDE Y; TIME FACTORS; YOUNG ADULT;

EID: 84883892739     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2013.04.020     Document Type: Article

References (16)

1. Berrettini W.H., Oxenstierna G., Sedvall G., Nurnberger J.I., Gold P.W., Rubinow D.R., Goldin L.R. Characteristics of cerebrospinal fluid neuropeptides relevant to clinical research. Psychiatry Res. 1988, 25:349-359.
2. Bowers M.E., Choi D.C., Ressler K.J. Neuropeptide regulation of fear and anxiety: implications of cholecystokinin, endogenous opioids, and neuropeptide Y. Physiol. Behav. 2012, 107:699-710.
3. Cohen H., Liu T., Kozlovsky N., Kaplan Z., Zohar J., Mathé A.A. The neuropeptide Y (NPY)-ergic system is associated with behavioral resilience to stress exposure in an animal model of post-traumatic stress disorder. Neuropsychopharmacology 2012, 37:350-363.
4. Dötsch J., Adelmann M., Englaro P., Dötsch A., Hänze J., Blum W.F., Kiess W., Rascher W. Relation of leptin and neuropeptide Y in human blood and cerebrospinal fluid. J. Neurol. Sci. 1997, 151:185-188.
5. Grouzmann E., Borgeat A., Fathi M., Gaillard R.C., Ravussin P. Plasma and cerebrospinal fluid concentration of neuropeptide Y, serotonin, and catecholamines in patients under propofol or isoflurane anesthesia. Can. J. Physiol. Pharmacol. 2000, 78:100-107.
6. Hamilton M.A. A rating scale for depression. J. Neurosurg. Psychiatry 1960, 23:56-62.
7. Hirsch D., Zukowska Z. NPY and stress 30 years later: the peripheral view. Cell. Mol. Neurobiol. 2012, 32:645-659.
8. Kastin A.J., Akerstrom V. Nonsaturable entry of neuropeptide Y into brain. Am. J. Physiol. 1999, 276:E479-E482.
9. Klemfuss H., Clopton P.L. Seeking tau: a comparison of six methods. J. Interdiscipl. Cycle Res. 1993, 24:1-16.
10. Löckinger A., Köberle D., König P.S., Saria A., Herold M., Cornélissen G., Halberg F. Neuropeptide chronomics in clinically healthy young adults: circaoctohoran and circadian patterns. Peptides 2004, 25:533-542.
11. Michel M.C., Beck-Sickinger A., Cox H., Doods H.N., Herzog H., Larhammar D., Quirion R., Schwartz T., Westfall T. XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol. Rev. 1998, 50:143-150.
12. Nam S.Y., Kratzsch J., Kim K.W., Kim K.R., Lim S.K., Marcus C. Cerebrospinal fluid and plasma concentrations of leptin, NPY, and alpha-MSH in obese women and their relationship to negative energy balance. J. Clin. Endocrinol. Metab. 2001, 86:4849-4853.
13. Sah R., Geracioti T.D. Neuropeptide Y and posttraumatic stress disorder. Mol. Psychiatry 2012, (Epub ahead of print). 10.1038/mp.2012.101.
14. Takiyyuddin M.A., Brown M.R., Dinh T.Q., Cervenka J.H., Braun S.D., Parmer R.J., Kennedy B., O'Connor D.T. Sympatho-adrenal secretion in humans: factors governing catecholamine and storage vesicle peptide co-release. J. Auton. Pharmacol. 1994, 14:187-200.
15. Zhang K., Rao F., Pablo Miramontes-Gonzalez J., Hightower C.M., Vaught B., Chen Y., Greenwood T.A., Schork A.J., Wang L., Mahata M., Stridsberg M., Khandrika S., Biswas N., Fung M.M., Waalen J., Middelberg R.P., Heath A.C., Montgomery G.W., Martin N.G., Whitfield J.B., Baker D.G., Schork N.J., Nievergelt C.M., O'Connor D.T. Neuropeptide Y (NPY): genetic variation in the human promoter alters glucocorticoid signaling, yielding increased NPY secretion and stress responses. J. Am. Coll. Cardiol. 2012, pii: S0735-1097(12)02953-1 (Epub ahead of print). 10.1016/j.jacc.2012.06.042.
16. Zhou Z., Zhu G., Hariri A.R., Enoch M.A., Scott D., Sinha R., Virkkunen M., Mash D.C., Lipsky R.H., Hu X.Z., Hodgkinson C.A., Xu K., Buzas B., Yuan Q., Shen P.H., Ferrell R.E., Manuck S.B., Brown S.M., Hauger R.L., Stohler C.S., Zubieta J.K., Goldman D. Genetic variation in human NPY expression affects stress response and emotion. Nature 2008, 452:997-1001.